| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.3 | 7e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |